PREP and colitis: To further ascertain whether AcSDKP plays an anti-inflammatory role in the intestine, which accounts for the increased vulnerability of PREP-KO mice to experimental colitis, female WT mice were treated with AcSDKP (1,600 μg/kg/day) or vehicle (saline solution) via mini-osmotic pumps, followed by 3% DSS induction.